Cargando…

The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review

Asthma is a heterogeneous syndrome that might be better described as a constellation of phenotypes or endotypes, each with distinct cellular and molecular mechanisms, rather than as a singular disease. One of these phenotypes is eosinophilic asthma. As the development of eosinophilic inflammation is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, Megan F, Borish, Larry, Kennedy, Joshua L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639549/ https://www.ncbi.nlm.nih.gov/pubmed/26604804 http://dx.doi.org/10.2147/JAA.S74178

Ejemplares similares

Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic
por: Eid, Ryan, et al.
Publicado: (2021)

Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report
por: Huguenot, Marc, et al.
Publicado: (2022)

Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports
por: Skouvaklidou, Elpida, et al.
Publicado: (2023)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
por: Pierpont, Timothy M., et al.
Publicado: (2018)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

Blood Eosinophil–directed Management of Airway Disease. The Past, Present, and Future
por: Pavord, Ian D.
Publicado: (2020)

Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
por: Zhang, Chuchu, et al.
Publicado: (2021)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report
por: Kagoshima, Hiroki, et al.
Publicado: (2020)

Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
por: Steinke, John W, et al.
Publicado: (2001)

Monoclonal Antibodies in Multiple Sclerosis: Present and Future
por: Voge, Natalia V., et al.
Publicado: (2019)

Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU
por: Barbarot, Nicolas, et al.
Publicado: (2022)

The Past, Present, and Future in Antinuclear Antibodies (ANA)
por: Irure-Ventura, Juan, et al.
Publicado: (2022)

Production of monoclonal antibodies reactive with ovine eosinophils
por: Sansome, Georgina M, et al.
Publicado: (2007)

Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future
por: Ramírez-Jiménez, Fernando, et al.
Publicado: (2023)

A review of Sarcoptes scabiei: past, present and future
por: Arlian, Larry G., et al.
Publicado: (2017)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Monoclonal Antibodies for Chronic Pain Treatment: Present and Future
por: Sánchez-Robles, Eva M., et al.
Publicado: (2021)

Diabetes Spectrum: Past, Present, and Future
por: Neumiller, Joshua J.
Publicado: (2018)

Anti‐interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis
por: Tomyo, Fuminori, et al.
Publicado: (2018)

Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
por: Jang, A. S., et al.
Publicado: (2000)

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series
por: Zhang, Lijia, et al.
Publicado: (2020)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Targeting IL-6 trans-signalling: past, present and future prospects
por: Rose-John, Stefan, et al.
Publicado: (2023)

Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody
por: Nishiyama, Hirono, et al.
Publicado: (2021)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma
por: Singh, Dave, et al.
Publicado: (2021)

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media
por: Chikumoto, Ayumi, et al.
Publicado: (2022)

The past, present and future of neutralizing antibodies for hepatitis C virus
por: Ball, Jonathan K., et al.
Publicado: (2014)

A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
por: Okude, Azusa, et al.
Publicado: (2012)

The Past, Present, and Future of Human Centromere Genomics
por: Aldrup-MacDonald, Megan E., et al.
Publicado: (2014)

Past, present and future
Publicado: (1982)

Past, present and future
Publicado: (2000)

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
por: Mollstedt, John, et al.
Publicado: (2023)

Supervised injection facilities in Canada: past, present, and future
por: Kerr, Thomas, et al.
Publicado: (2017)

Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
por: Patterson, Stephen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p903m606367o145qn5qvnbvum8